Hypothesis\nAging‑associated NAD+ decline is not a passive consequence of damage but an active, circadian‑gated decision: when the suprachiasmatic nucleus (SCN) perceives prolonged circadian misalignment, it downregulates NAMPT amplitude, lowering NAD+ to enforce a cellular low‑energy state that limits SASP and conserves resources. If light‑driven entrainment restores robust NAMPT oscillations, NAD+ levels rise and the cell reallocates energy toward repair and identity maintenance; if entrainment fails, the low‑NAD+ state becomes chronic, tipping the balance toward senescence‑associated inflammation.\n\n## Mechanistic Basis\n- The SCN drives daily NAMPT transcription via BMAL1/CLOCK binding to the Nampt promoter, creating NAD+ peaks that activate SIRT1 and SIRT3, promoting DNA repair and mitochondrial fidelity [3].\n- Chronic light at night or shift‑work blunts this rhythm, reducing NAD+ trough‑to‑peak amplitude, which diminishes SIRT1 deacetylation of PER2, further weakening clock stability [5].\n- Low NAD+ limits PARP‑1 activity, slowing DNA‑break signaling, and reduces CD38‑mediated NAD+ consumption, thereby dampening the SASP [2, 7].\n- Thus NAD+ functions as a metabolic checkpoint: sufficient levels fund ambitious repair programs; insufficient levels trigger a conservational retreat.\n\n## Testable Predictions\n1. In aged mice, restoring high‑amplitude NAMPT oscillations—by timed bright‑light exposure during the subjective day—will increase nuclear NAD+ levels by ≥30 % compared with constant dim light, without altering NAMPT expression levels.\n2. This NAD+ rescue will correlate with heightened SIRT1 activity, reduced γH2AX foci, and a proportional decrease in SASP cytokines (IL‑6, IL‑1β) in peripheral blood.\n3. Conversely, inducing chronic circadian disruption (constant light) in young mice will reproduce the aged NAD+ low‑amplitude phenotype and prematurely elevate SASP, even when DNA damage is held constant by low‑dose irradiation.\n4. Pharmacological inhibition of CD38 will not normalize NAD+ rhythms under circadian disruption, indicating that the primary defect lies upstream of consumption.\n\n## Experimental Design\n- Subjects: 24‑month‑old C57BL/6 mice (n=12 per group) and 3‑month‑old counterparts.\n- Groups: (i) Control dim‑light (5 lux) 12:12 LD; (ii) Timed bright‑light (1000 lux) 2‑h pulse at ZT4; (iii) Constant bright‑light (1000 lux) arrhythmic; (iv) Constant bright‑light + NAMPT overexpression via AAV9‑Nampt (to test sufficiency).\n- Measurements: Serial blood draws every 4 h for 48 h to quantify NAD+ (LC‑MS/MS), NAMPT protein (Western blot), SIRT1 activity (acetyl‑p53 assay), DNA damage (γH2AX immunofluorescence in liver), SASP cytokines (ELISA).\n- Analysis: Cosinor rhythmometry to extract amplitude, mesor, and acrophase; two‑way ANOVA for group×time effects; mediation analysis to test whether NAD+ amplitude mediates the effect of light condition on SASP.\n\n## Potential Confounds\n- Light exposure can affect corticosterone and melatonin, which independently influence NAD+ metabolism; we will measure hormone levels to include as covariates.\n- Age‑related retinal degeneration may alter light perception; we will use ERG testing to confirm comparable photic input across age groups.\n- Microbiota shifts with aging could affect NAD+ precursors; cohousing controls will be employed.\n\n## Implications\nIf validated, this hypothesis reframes NAD+ decline as a tunable, circadian‑controlled metabolic checkpoint rather than a irreversible wear‑and‑tear signal. It predicts that circadian hygiene—specifically, timed bright‑light exposure that reinforces endogenous NAMPT rhythms—could rejuvenate NAD+‑dependent repair pathways more sustainably than chronic supplementation, turning darkness and light into programmable ‘nootropics’ for longevity.